Public Pharma in Sweden: The APL Case
Public Pharma, as articulated by the People’s Health Movement (PHM), refers to the research, development, manufacturing, and distribution of health technologies carried out under public ownership, with the explicit aim of serving collective health needs rather than private profit. It is understood not merely as a corrective to so‑called market failures, but as a systemic infrastructure that redefines medicines and health technologies as public goods.